Malin Corporation

Malin Corporation

A global life sciences company, focusing on the therapeutics, devices, and diagnostics space.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€303m

Valuation: €324m

IPO
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2018201920202021202220232024
Revenues0000000000000000000000000000
% growth(7 %)(8 %)17 %----
EBITDA0000000000000000000000000000
% EBITDA margin(45 %)(15 %)5 %----
Profit0000000000000000000000000000
% profit margin(121 %)(15 %)214 %----
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue-8 %16 %----

Source: Company filings or news article

More about Malin Corporation
Made with AI
Edit

Malin plc is a publicly listed company headquartered in Ireland, specializing in investing in highly innovative life sciences companies. The company focuses on sectors such as oncology, immunology, and genetic diseases, where advanced life science and healthcare technologies have the potential to deliver transformative treatments for patients. Malin's business model revolves around providing long-term capital and strategic support to its investee companies, enabling them to reach their full value potential. The company aims to generate significant returns for its shareholders while achieving transformative outcomes for patients. Malin serves a diverse range of clients, primarily in the life sciences and healthcare sectors, and operates within the global market. The company makes money through capital appreciation and returns on its investments in these high-potential life sciences companies. The senior leadership team at Malin brings extensive expertise in life sciences, finance, and venture capital, ensuring a dynamic and strategically aware approach to investment.

Keywords: life sciences, oncology, immunology, genetic diseases, transformative treatments, long-term capital, strategic support, shareholder value, innovative technologies, healthcare investments.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
  • Edit
Kymab
ACQUISITION by Sanofi Jan 2021
3D4Medical.com
ACQUISITION by Elsevier Nov 2019
Poseida Therapeutics
ACQUISITION by Roche Nov 2024
Altan Pharma
ACQUISITION by Ethypharm Jun 2021
Altan Pharma
ACQUISITION by Malin Corporation Jun 2015